Skip to main content
Shionogi & Co.,Ltd. logo

Shionogi & Co.,Ltd. — Investor Relations & Filings

Ticker · 4507 ISIN · JP3347200002 LEI · 35380049VXDTHZI3DY35 T Manufacturing
Open in API
Filings indexed 76 across all filing types
Latest filing 2023-11-10 Interim / Quarterly Rep…
Country JP Japan
Listing T 4507

About Shionogi & Co.,Ltd.

https://www.shionogi.com/global/en/

Shionogi & Co., Ltd. is a drug discovery-based pharmaceutical company that researches, develops, manufactures, and markets a portfolio of prescription drugs, over-the-counter (OTC) products, and diagnostic reagents. The company prioritizes addressing unmet medical needs, with a significant focus on infectious diseases, including antibiotics, HIV, influenza, and COVID-19. A key strategic area is the development of solutions to combat antimicrobial resistance (AMR). Historically, the company is known for the development of Crestor, a widely used statin. Shionogi aims to provide innovative products and services to improve global health outcomes.

Recent filings

Filing Released Lang Actions
四半期報告書－第159期第2四半期(2023/07/01－2023/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed under the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements, management analysis (MD&A), and corporate information for the second quarter of the 159th fiscal period (ending September 30, 2023). As it is a comprehensive financial report for a period shorter than a full fiscal year containing substantive financial data, it is classified as an Interim/Quarterly Report. H1 2024
2023-11-10 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan. It serves as a formal certification by the CEO regarding the accuracy of the quarterly report for the first quarter of the 159th fiscal period. Since it is a regulatory filing required by law to accompany financial reports but does not contain the financial statements themselves, and does not fit into specific categories like '10-K' or 'IR', it is classified as a general regulatory filing.
2023-08-09 Japanese
四半期報告書－第159期第1四半期(2023/04/01－2023/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a Japanese 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements, management analysis, and audit review information for the first quarter of the 159th fiscal period (April 1, 2023, to June 30, 2023). This fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial data and analysis for a period shorter than a full fiscal year. Q1 2023
2023-08-09 Japanese
内部統制報告書－第158期(2022/04/01－2023/03/31)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act in Japan. It details the framework, scope, and results of the company's internal controls over financial reporting. Since this is a standalone regulatory filing regarding internal control assessment and does not fit into the specific categories of Annual Reports (10-K) or general regulatory announcements (RNS), it is best classified as an Audit Report/Information (AR), as it pertains to the audit/assessment of internal control systems.
2023-06-22 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, Article 24-4-2, Paragraph 1. This is a mandatory internal control certification filed alongside the Annual Securities Report (Yukashoken Hokokusho) in Japan. Since it is a regulatory filing confirming the accuracy of the annual report and does not constitute the annual report itself, it falls under the 'Regulatory Filings' category. FY 2023
2023-06-22 Japanese
有価証券報告書－第158期(2022/04/01－2023/03/31)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of an Annual Report (10-K). The header explicitly identifies it as a 'Securities Report' (有価証券報告書) filed under the Financial Instruments and Exchange Act, covering the fiscal year from April 1, 2022, to March 31, 2023. It contains extensive XBRL tagging and financial data, confirming it is the full annual report rather than an announcement or summary. FY 2023
2023-06-22 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.